Raleigh, NC and MALMÖ, Sweden – (August 16, 2022) – Trialbee, the leader in data and technology-based patient matching and enrollment for clinical trials, today announced the appointment of Dotdash Meredith digital content leader Rachel Berman, digital healthcare evangelist Ritesh Patel, and WebMD CMO, Dr. John Whyte to Trialbee’s Advisory Board.

The board functions as an innovation council that offers insight and expertise across the entire spectrum of clinical research to develop new solutions and supercharge enrollment performance. Berman, Patel, and Whyte join the Advisory Board at a time when 80% of trials fail to meet enrollment timelines, the healthcare landscape is undergoing generational shifts, and clinical trial sponsors are facing an anticipated 50,000 clinical trials that will require 125 million patients over the next five years.

“Trialbee’s significant momentum comes as the clinical trial space rapidly evolves with technology and data-driven solutions that break down barriers to clinical trial participation,” says Trialbee CEO Matt Walz. “Our Trialbee Honey™ platform and use of real world data solves difficult challenges for sponsors, CROs, and trial sites, but innovation also benefits from the expertise of a group like our Advisory Board, which represents a range of disciplines within life sciences and the broader healthcare ecosystem. We look forward to having our new Advisory Board members support our growth as we navigate the opportunities to advance patient recruitment in this new era with patient-centricity as a top priority.”

Berman, who serves as Senior Vice President and Group GM for Family and Wellness at Dotdash Meredith, is a Registered Dietitian (RD) and an award-winning digital health executive. Berman has been instrumental in driving strategy, content, partnerships and leading the rapid growth of multiple consumer health and parenting brands.

Patel serves as Senior Partner, Global Digital Health at FINN Partners and has been a digital evangelist since the late 1990s. His primary focus is on digital strategy, tools, platforms, and ecosystems in healthcare, and he has extensive experience in online marketing, advertising, sales, CRM, and digital business development. Before FINN Partners, Patel worked at Ogilvy for more than seven years, including the last four as Chief Digital Officer, focused on digital transformation and innovation for clients in pharma, health systems, device manufacturers, and payers.

Whyte is a visionary, results-driven senior executive, physician, writer, and healthcare policy expert with more than two decades of healthcare leadership and policy development experience. During three years in his current role with WebMD, Whyte has led efforts to develop and expand strategic partnerships. Prior to WebMD, Whyte served as Director of Professional Affairs and Stakeholder Engagement at the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration.

“Our Industry Advisory Board is ideally positioned to keep Trialbee at the forefront of clinical research innovation, including our recent additions who provide immense digital acumen and deep healthcare experience,” says Trialbee Industry Advisory Board Chair Craig Lipset, Managing Partner, Clinical Innovation Partners.

Berman, Patel, and Whyte join several other Advisory Board members who represent pharmaceutical companies, medical device manufacturers, clinical research organizations, and other leaders in the healthcare space, including:

About Trialbee

Trialbee is the leading global data and technology platform for patient matching and enrollment in clinical trials. Trialbee Hive™ operationalizes real world data (RWD) and applies data science to match patients globally. Trialbee Honey™ simplifies the journey for matched patients, reduces the burden of enrolling patients for sites and provides real-time, data-driven insights to sponsors and CROs so they can optimize enrollment timelines. Partnering with sponsors, CROs, and virtual/decentralized sites and software providers, Trialbee is achieving patient enrollment goals and driving enhancements in diversity in clinical trial populations. We are the smartest way to match and enroll patients for your clinical trial. For more information, visit http://www.trialbee.com or contact us at solutions@trialbee.com.


Matt McLoughlin
Gregory FCA (for Trialbee)